Intarcia Therapeutics Secures $206,000,000 Series E Financing Round

  • Feed Type
  • Date
  • Company Name
    Intarcia Therapeutics
  • Mailing Address
    155 Seaport Boulevard 11th Floor Boston, MA 02210 USA
  • Company Description
    Intarcia Therapeutics, Inc., is a rapidly emerging biopharmaceutical company committed to developing innovative therapies that merge medicine with technology, and have the potential to transform therapeutic categories.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series E
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Bill & Melinda Gates Foundation
  • Venture Investor

Trending on Xconomy